Yohimbe (Pausinystalia johimbe)
What Is Yohimbe?
Yohimbe is the common name for Pausinystalia johimbe, a plant of the Rubiaceae family, native to the rainforests of West and Central Africa. The material in circulation is bark — bark, stripped from stem or trunk. The common name Yohimbe and the botanical name Pausinystalia johimbe refer to the same material, and labels may use either — a detail that matters when related species in the same genus are not interchangeable. Its character is described as bitter, woody, tannic, which is often how the raw material is checked for quality.
In African traditional medicine, Yohimbe is a long-standing entry. Its use is carried largely through oral transmission among traditional healers, and it entered the written record comparatively late, through colonial-era botanical surveys and modern ethnobotanical fieldwork. Beyond its practical use it carries cultural associations — cameroonian and Gabonese bark of vigour and stamina.
Today most searches for Yohimbe come from people reading about anxiety and libido, or checking how it sits alongside a medication they already take. The use most often documented in the literature is yohimbine is a licensed prescription agent for erectile dysfunction in some countries, followed by alpha-2 antagonism studied for SSRI-induced sexual dysfunction.
How Does Yohimbe Work?
Yohimbe is not a single active substance. Its chemistry is a mixture, and the fractions that researchers isolate most often are Alkaloids. Alkaloids is the fraction most often standardised in extracts, associated in the literature with bioactive nitrogen-containing compounds.
African traditional practice situates a plant within community, season and preparation ritual as much as within its chemistry. That older description was arrived at without chemistry, and it does not map neatly onto constituent names — but it records centuries of observation about dose, preparation and who the plant suited.
The research base is developing: there are human trials, though sample sizes and designs vary, and this profile cites 2 sources. Reported findings centre on bark contains roughly 1–6% yohimbine plus corynanthine and related alkaloids. Where research exists, it examines yohimbine is a licensed prescription agent for erectile dysfunction in some countries, alpha-2 antagonism studied for SSRI-induced sexual dysfunction and research tool for noradrenergic anxiety models. These are areas of study, not established outcomes, and results differ by preparation and dose.
How the plant is prepared changes what you actually get. Its constituents move readily into alcohol — so a preparation made in another medium will not carry the same fraction of the plant, which is why traditional recipes specify one over another.
The reason Yohimbe is treated as its own entry rather than a substitute for a related plant is proportion: related species share several of these compound classes, but not in the same ratio or concentration.
Because these constituents are processed by the same pathways that handle many medicines, Yohimbe is documented as interacting with mao inhibitors, tricyclic antidepressants and stimulants. That is a question of shared metabolism rather than of potency, and it is the main reason the plant is listed in interaction references at all.
Dose, plant part and growing conditions all shift the constituent profile, so two products carrying the name Yohimbe can differ substantially; this is why reference entries specify bark and, where they exist, standardisation markers.